Sentiment-Signal
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
HOCH Abgang Schlüsselpersonen (25.02.2026)
HOCH Abgang Schlüsselpersonen (25.02.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo |
| 25.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appo |
| 14.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 13.08.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 12.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; App |
| 08.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Ap |
| 06.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; App |
| 03.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ection 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; App |
| 07.12.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | the New York Stock Exchange on December 8, 2023. Item 5.02. Departure of Directors or Certain Officers; Election of D |
| 26.09.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | on 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appoint |
Stammdaten
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Unternehmen & Branche
| Name | Avantor, Inc. |
|---|---|
| Ticker | AVTR |
| CIK | 0001722482 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3826 · Laboratory Analytical Instruments |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 5,36 Mrd. USD |
| Beta | 1,00 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 6,552,200,000 | -530,200,000 | -0.78 | 11,794,700,000 | 5,565,000,000 |
| 2025-09-30 | 10-Q | 1,623,800,000 | -711,800,000 | -1.04 | 11,675,900,000 | 5,570,200,000 |
| 2025-06-30 | 10-Q | 1,683,400,000 | 64,700,000 | 0.09 | 12,776,900,000 | 6,285,900,000 |
| 2025-03-31 | 10-Q | 1,581,400,000 | 64,500,000 | 0.09 | 12,326,400,000 | 6,098,200,000 |
| 2024-12-31 | 10-K | 6,783,600,000 | 711,500,000 | 1.04 | 12,114,500,000 | 5,956,700,000 |
| 2024-09-30 | 10-Q | 1,714,400,000 | 57,800,000 | 0.08 | 12,840,600,000 | 5,553,200,000 |
| 2024-06-30 | 10-Q | 1,702,800,000 | 92,900,000 | 0.14 | 12,693,500,000 | 5,435,000,000 |
| 2024-03-31 | 10-Q | 1,679,800,000 | 60,400,000 | 0.09 | 12,763,400,000 | 5,336,300,000 |
| 2023-12-31 | 10-K | 6,967,200,000 | 321,100,000 | 0.47 | 12,972,700,000 | 5,252,600,000 |
| 2023-09-30 | 10-Q | 1,720,200,000 | 108,400,000 | 0.16 | 12,798,100,000 | 5,099,400,000 |
| 2023-06-30 | 10-Q | 1,743,900,000 | -7,300,000 | -0.01 | 13,063,300,000 | 5,011,300,000 |
| 2023-03-31 | 10-Q | 1,780,300,000 | 121,500,000 | 0.18 | 13,395,900,000 | 4,994,600,000 |
| 2022-12-31 | 10-K | 7,512,400,000 | 686,500,000 | 1.01 | 13,464,300,000 | 4,855,400,000 |
| 2022-09-30 | 10-Q | 1,856,500,000 | 167,000,000 | 0.25 | 13,113,300,000 | 4,591,400,000 |
| 2022-06-30 | 10-Q | 1,910,500,000 | 187,400,000 | 0.28 | 13,430,900,000 | 4,469,500,000 |
| 2022-03-31 | 10-Q | 1,950,400,000 | 190,400,000 | 0.28 | 13,836,400,000 | 4,358,000,000 |
| 2021-12-31 | 10-K | 7,386,100,000 | 572,600,000 | 0.85 | 13,897,200,000 | 4,197,000,000 |
| 2021-09-30 | 10-Q | 1,834,300,000 | 156,800,000 | 0.24 | 12,199,200,000 | 4,104,800,000 |
| 2021-06-30 | 10-Q | 1,858,600,000 | 157,800,000 | 0.24 | 11,249,700,000 | 2,985,900,000 |
| 2021-03-31 | 10-Q | 1,785,600,000 | 164,000,000 | 0.25 | 9,738,800,000 | 2,806,100,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | MEHRA SANJEEV K | Director | Open Market Purchase | 125,000 | 8.01 | 1,001,250.00 | +103,7% | |
| 2026-02-19 | LUCIER GREGORY T | Director | Open Market Purchase | 50,000 | 9.16 | 458,000.00 | +47,4% | |
| 2026-02-12 | SUMME GREGORY L | Director | Open Market Purchase | 100,000 | 9.40 | 940,000.00 | +97,3% | |
| 2025-12-05 | MEHRA SANJEEV K | Director | Open Market Purchase | 350,000 | 11.09 | 3,881,500.00 | +401,9% | |
| 2025-11-17 | Ligner Emmanuel | Director, Officer, President and CEO | Open Market Purchase | 87,500 | 11.35 | 993,125.00 | +102,8% | |
| 2025-10-30 | SUMME GREGORY L | Director | Open Market Purchase | 100,000 | 11.25 | 1,125,000.00 | +116,5% | |
| 2025-08-21 | SUMME GREGORY L | Director | Open Market Purchase | 100,000 | 12.56 | 1,256,000.00 | +130,1% | |
| 2025-08-05 | Eck Steven W | Officer, SVP & Chief Accounting Officer | Open Market Sale | -3,476 | 11.39 | -39,591.64 | -4,1% | |
| 2025-05-23 | SUMME GREGORY L | Director | Open Market Purchase | 30,000 | 12.50 | 375,000.00 | +38,8% | |
| 2025-05-22 | SUMME GREGORY L | Director | Open Market Purchase | 20,000 | 12.65 | 253,000.00 | +26,2% | |
| 2025-05-07 | SUMME GREGORY L | Director | Open Market Purchase | 25,000 | 12.00 | 300,000.00 | +31,1% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.